A detailed history of New Edge Advisors, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,903 shares of RXST stock, worth $85,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,903
Previous 1,903 -0.0%
Holding current value
$85,311
Previous $114,000 17.54%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$50.42 - $64.29 $3,882 - $4,950
-77 Reduced 3.89%
1,903 $114,000
Q2 2023

Aug 14, 2023

SELL
$16.37 - $28.9 $2,291 - $4,046
-140 Reduced 6.6%
1,980 $57,000
Q1 2023

May 12, 2023

BUY
$12.58 - $16.68 $5,283 - $7,005
420 Added 24.71%
2,120 $35,000
Q4 2022

Feb 14, 2023

BUY
$9.93 - $14.2 $16,881 - $24,140
1,700 New
1,700 $21,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.